Advanced in Hepatic Venoocclusive Disease with Immunodeficiency

Florent Malard

Paris, FR 
Advanced in Hepatic Venoocclusive Disease with Immunodeficiency
Paris, FR 
OverviewLocationsClinical Research

Overview

Florent Malard practices in Paris, France. Mr. Malard is rated as an Advanced expert by MediFind in the treatment of Hepatic Venoocclusive Disease with Immunodeficiency. His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Multiple Myeloma, Bone Marrow Transplant, and Bone Graft.

His clinical research consists of co-authoring 197 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Hepatic Venoocclusive Disease with Immunodeficiency.

Gender
Male

Locations

Paris, France
Other Locations
Saint Antoine, France
Rennes, 35000, France
Nantes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Evaluation of the Efficacy of MaaT013 As Salvage Therapy in Acute GVHD Patients with Gastrointestinal Involvement, Refractory to Ruxolitinib; a Multi-center Open-label Phase III Trial.
Evaluation of the Efficacy of MaaT013 As Salvage Therapy in Acute GVHD Patients with Gastrointestinal Involvement, Refractory to Ruxolitinib; a Multi-center Open-label Phase III Trial.
Enrollment Status: Active_not_recruiting
Publish Date: October 17, 2024
Intervention Type: Drug
Study Phase: Phase 3
Safety Phase I Evaluation of MaaT033, a Lyophilized Full-ecosystem Gut Microbiota Delayed-release Capsule, In HeMatOlogy Malignant Patients Under iNtensive Chemotherapy (CIMON)
Safety Phase I Evaluation of MaaT033, a Lyophilized Full-ecosystem Gut Microbiota Delayed-release Capsule, In HeMatOlogy Malignant Patients Under iNtensive Chemotherapy (CIMON)
Enrollment Status: Completed
Publish Date: April 12, 2022
Intervention Type: Drug
Study Phase: Phase 1
Treatment of Steroid Refractory Gastro-intestinal Acute Graft-versus-Host disEase afteR AllogeneiC Hematopoietic Stem celL Transplantation With fEcal Microbiota tranSfer
Treatment of Steroid Refractory Gastro-intestinal Acute Graft-versus-Host disEase afteR AllogeneiC Hematopoietic Stem celL Transplantation With fEcal Microbiota tranSfer
Enrollment Status: Completed
Publish Date: February 23, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

197 Total Publications

Emerging novel therapies for steroid-refractory acute graft-versus-host disease: recent advances and future directions.
Emerging novel therapies for steroid-refractory acute graft-versus-host disease: recent advances and future directions.
Journal: Current opinion in immunology
Published: July 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Malard's expertise for a condition
ConditionClose
View All 34 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile